Dictionary
The Dictionary provides concise definitions of health economics terms, arranged alphabetically for quick reference. Use it to understand unfamiliar terminology or confirm the meaning of a specific term.
H
- Hepatology EconomicsLiver Economics, Hepatobiliary Economics
- The application of health economic evaluation to the broader field of liver disease, covering viral hepatitis, fatty liver disease, cirrhosis, and liver cancer.
- Hernia EconomicsHernia Repair Economics, Herniorrhaphy Economics
- The application of health economic evaluation to hernia repair, comparing open versus laparoscopic surgery and different mesh material choices.
- Herpes EconomicsHSV Economics, Herpesvirus Economics
- The application of health economic evaluation to herpes virus infections, covering herpes simplex virus and varicella-zoster related conditions such as shingles.
- HIV EconomicsHIV/AIDS Economics, AIDS Economics
- The application of health economic evaluation to HIV infection, covering prevention, testing, and lifelong antiretroviral treatment.
- Home Care EconomicsDomiciliary Care Economics, Home Health Economics
- The application of health economic evaluation to healthcare and support delivered in a patient's own home rather than a hospital or care home.
- Hospice EconomicsHospice Care Economics, Terminal Care Economics
- The application of health economic evaluation to palliative, comfort-focused hospice services for patients with terminal illness and limited life expectancy.
- HPV EconomicsHuman Papillomavirus Economics, HPV Vaccine Economics
- The application of health economic evaluation to human papillomavirus infection and its associated cancers, covering vaccination and cervical screening strategies.
- Hyperglycemia EconomicsEconomics of Hyperglycaemia, High Blood Glucose Economics
- The application of health economic evaluation to elevated blood glucose and its management, from acute episodes to chronic poorly controlled diabetes.
- Hyperlipidemia EconomicsEconomics of Hyperlipidaemia, High Cholesterol Economics
- The application of health economic evaluation to elevated blood lipid levels, assessing lipid-lowering medication cost against long-term cardiovascular benefit.
- Hypertension EconomicsEconomics of Hypertension, High Blood Pressure Economics
- The application of health economic evaluation to high blood pressure, comparing medication classes and combinations for cost-effectiveness in cutting cardiovascular events.
- Hypoglycemia EconomicsEconomics of Hypoglycaemia, Low Blood Glucose Economics
- The application of health economic evaluation to episodes of abnormally low blood glucose, a risk particularly associated with insulin therapy.
I
- Immunology EconomicsEconomics of Immunology, Immune Disease Economics
- The application of health economic evaluation to conditions involving the immune system, covering autoimmune disease, immunodeficiency, and allergic conditions.
- Immunotherapy EconomicsImmuno-Oncology Economics, Economics of Immunotherapy
- The application of health economic evaluation to cancer immunotherapy, comparing substantial upfront cost against durable clinical responses observed in some patients.
- Incontinence Economics
- The application of health economic evaluation to urinary and faecal incontinence, covering behavioural therapy, medication, devices, and surgery.
- Infection Control EconomicsEconomics of Infection Control, IPC Economics
- The application of health economic evaluation to preventing infection transmission in healthcare settings, covering hand hygiene, isolation, and environmental cleaning.
- Infection Prevention EconomicsEconomics of Infection Prevention, Preventive IPC Economics
- The application of health economic evaluation to strategies preventing infections before they occur, spanning vaccination, hygiene promotion, and environmental interventions.
- Infectious Disease EconomicsEconomics of Infectious Disease, Communicable Disease Economics
- The broad application of health economic evaluation to the prevention, diagnosis, and treatment of diseases caused by pathogenic microorganisms.
- Influenza EconomicsFlu Economics, Economics of Influenza
- The application of health economic evaluation to seasonal and pandemic influenza, covering annual vaccination programmes and antiviral treatment strategies.
- Informal Care EconomicsEconomics of Informal Care, Unpaid Care Economics
- The application of health economic evaluation to unpaid care from family or friends, covering both caregiving time and its effect on the carer.
- Injury Prevention EconomicsEconomics of Injury Prevention, Safety Intervention Economics
- The application of health economic evaluation to programmes reducing unintentional and intentional injuries, spanning road, workplace, and violence prevention.
- Insulin EconomicsEconomics of Insulin, Insulin Therapy Economics
- The application of health economic evaluation to insulin therapy, comparing formulations, delivery devices, and treatment regimens for diabetes management.
- Insulin Pump EconomicsInsulin Pump Therapy Economics, CSII Economics
- The application of health economic evaluation to insulin pump therapy, a device delivering insulin more precisely than multiple daily injections.
- Interventional Cardiology EconomicsEconomics of Interventional Cardiology, Cath Lab Economics
- The application of health economic evaluation to catheter-based cardiac procedures, comparing cost and outcomes against surgical alternatives and medical management.
- Ischaemic Stroke EconomicsEconomics of Ischaemic Stroke, Ischemic Stroke Economics
- The application of health economic evaluation to strokes from blocked brain blood flow, assessing time-sensitive clot-dissolving drugs and thrombectomy.
J
- Joint Replacement EconomicsArthroplasty Economics, Hip and Knee Replacement Economics
- The application of health economic evaluation to joint replacement surgery, most commonly hip and knee, comparing timing, implants, and rehabilitation.
K
- Kidney Transplant EconomicsRenal Transplant Economics, Economics of Kidney Transplantation
- The application of health economic evaluation to kidney transplantation, weighing procedure and lifelong immunosuppression costs against benefit relative to long-term dialysis.
L
- Leishmaniasis Economics
- The application of health economic evaluation to leishmaniasis, a sandfly-transmitted parasitic disease endemic to parts of the tropics and subtropics.
- Lifetime HorizonLifetime Time Horizon, Whole-of-Life Horizon
- A time horizon for an economic evaluation extending over the remaining expected lifespan of the population studied, rather than a shorter follow-up period.
- Liver Disease EconomicsHepatic Disease Economics, Hepatic Illness Economics
- The application of health economic evaluation to conditions affecting the liver, spanning viral hepatitis, fatty liver disease, cirrhosis, and liver failure.
- Liver Transplant EconomicsHepatic Transplant Economics, Liver Graft Economics
- The application of health economic evaluation to liver transplantation, weighing procedure and lifelong immunosuppression costs against survival benefit for end-stage disease.
- Lupus EconomicsSLE Economics, Systemic Lupus Erythematosus Cost
- The application of health economic evaluation to systemic lupus erythematosus, a chronic autoimmune condition with unpredictable flares affecting multiple organs.
M
- Macular Degeneration EconomicsAMD Economics, Age-Related Macular Degeneration Cost
- The application of health economic evaluation to age-related macular degeneration, comparing anti-VEGF injectable treatments and their administration schedules.
- Malaria EconomicsMalaria Cost of Illness, Malaria Burden Economics
- The application of health economic evaluation to malaria, a mosquito-borne parasitic disease, covering vector control, preventive treatment, vaccination, and treatment.
- Maternal Health EconomicsMaternal Care Economics, Obstetric Health Economics
- The application of health economic evaluation to healthcare services during pregnancy, childbirth, and the postpartum period.
- Measles EconomicsMeasles Cost of Illness, Rubeola Economics
- The application of health economic evaluation to measles, a highly contagious viral disease largely preventable through vaccination.
- Medicinal ProductMedicine, Pharmaceutical Product, Drug Product
- In health economics, a manufactured product containing one or more active substances used to treat, prevent, or diagnose disease, and the unit whose price, value, and reimbursement pharmacoeconomic evaluation assesses.
- Meningitis EconomicsMeningococcal Economics, Meningitis Cost of Illness
- The application of health economic evaluation to meningitis, an infection of the brain and spinal cord membranes caused by various bacterial and viral pathogens.
- Mental Health EconomicsPsychiatric Economics, Behavioural Health Economics
- The broad application of health economic evaluation to mental health conditions and treatment, spanning prevention, psychotherapy, medication, and specialist psychiatric services.
- Metabolic Disease EconomicsMetabolic Syndrome Economics, Endocrine Disease Economics
- The application of health economic evaluation to conditions involving disrupted metabolic processes, including diabetes, obesity, and metabolic syndrome.
- Migraine EconomicsHeadache Economics, Migraine Cost of Illness
- The application of health economic evaluation to migraine, comparing acute treatment, preventive medication, and newer targeted therapies for this recurrent, often disabling condition.
- Model-Based EvaluationModel-Based Analysis, Decision-Model Evaluation
- An economic evaluation built using a mathematical or simulation model that synthesises evidence from multiple sources rather than a single study.
- MRSA EconomicsMRSA Cost of Illness, Methicillin-Resistant Staph Economics
- The application of health economic evaluation to methicillin-resistant Staphylococcus aureus, a common and serious antimicrobial-resistant bacterial pathogen.
- Multi-Sectoral AnalysisCross-Sectoral Analysis, Intersectoral Evaluation
- An economic evaluation considering costs and benefits arising across more than one sector, such as health, education, and social care.
- Multiple Sclerosis EconomicsMS Economics, Multiple Sclerosis Cost of Illness
- The application of health economic evaluation to multiple sclerosis, comparing an expanding range of disease-modifying therapies with varying costs and efficacy.
- Mumps EconomicsMumps Cost of Illness, Parotitis Economics
- The application of health economic evaluation to mumps, a viral infection largely preventable through standard childhood immunisation programmes.
- Musculoskeletal EconomicsMSK Economics, Bone and Joint Economics
- The broad application of health economic evaluation to bone, joint, muscle, and connective tissue conditions, spanning arthritis, osteoporosis, and injury.
- Myocardial Infarction EconomicsHeart Attack Economics, AMI Economics
- The application of health economic evaluation to heart attack diagnosis and treatment, covering emergency reperfusion therapy, medication, and rehabilitation costs.
N
- Neglected Disease EconomicsNTD Economics, Neglected Tropical Disease Economics
- The application of health economic evaluation to diseases disproportionately affecting low-income populations with historically limited research and development investment.
- Neonatal EconomicsNewborn Economics, NICU Economics
- The application of health economic evaluation to newborn care, particularly infants requiring specialist care for prematurity or congenital conditions.
- Nephrology EconomicsRenal Economics, Kidney Care Economics, Renal Disease Economics
- The broad application of health economic evaluation to kidney-related conditions, spanning chronic kidney disease, dialysis, and kidney transplantation.